Sign in

OxyContin and the opioid epidemic

1996Big moment

Purdue Pharma launches OxyContin with marketing that plays down addiction risk. Prescription opioids begin a U.S. epidemic of overdose deaths.

The story

In 1996, Purdue Pharma, a privately held company owned by the Sackler family, launched OxyContin, a tablet of oxycodone designed to release the drug slowly over about 12 hours. The Food and Drug Administration had approved it in December 1995. Purdue promoted it for common pain, not only for cancer patients and the dying, and trained a large sales force to visit doctors, offering free trial coupons and sales bonuses. The labeling and marketing suggested that the slow-release design made addiction rare and that patients could be treated for long periods.

Opioids come from the opium poppy, and the active ingredient morphine had been isolated in the early 1800s; oxycodone was first synthesized in Germany in 1916. Doctors had long been wary of prescribing opioids for non-cancer pain because of addiction. In the 1980s and 1990s many pain specialists argued that pain was undertreated, and a 1980 five-sentence letter in the New England Journal of Medicine, which noted few addictions among hospitalized patients given opioids, was widely cited to support the claim that addiction risk was under one percent. Purdue used that environment, even though the data did not apply to long-term outpatient use.

Prescriptions rose steeply, and so did misuse. Crushing the tablet defeated the slow-release mechanism and gave a heroin-like rush. Overdose deaths from opioids climbed through the 2000s, and roughly 500,000 Americans died of opioid overdoses between 1999 and 2019. In 2007 Purdue and three executives pleaded guilty to misleading the public about addiction risk, and the company paid about 634 million dollars. As prescriptions were restricted, many users turned to heroin, and from about 2013 to illicit fentanyl, a far stronger synthetic opioid. Purdue filed for bankruptcy in 2019, and lawsuits by states and cities produced settlements worth billions.

Why it mattered

  • Illicit fentanyl replaced prescription pills as the main driver of overdose deaths from about 2013, causing the deadliest wave of the crisis.
  • Doctors and regulators tightened rules on opioid prescribing, including state monitoring programs and federal guidelines in 2016.
  • Litigation against manufacturers and distributors produced tens of billions of dollars in settlements for states and local governments.
  • U.S. life expectancy stalled and then fell in the 2010s, partly because of drug overdose deaths.

Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made

Community notes

Loading notes…

Learn more ranked by votes

BookPatrick Radden Keefe
Empire of Pain
Search Open Library
BookBeth Macy
Dopesick
Search Open Library
VideoSearch YouTube
OxyContin opioid epidemic history
Search YouTube